Liposomal supplements offer a breakthrough in nutrient absorption, allowing the body to better utilise essential vitamins and antioxidants.

Akagera Medicines, a Rwandan biotech company has announced promising results after completing early stages of preclinical trials of an antibiotic drug for the treatment of pulmonary tuberculosis (TB).

Giant unilamellar vesicles (GUVs), which lack metabolic activity, served as a controlled model for studying the purely ...

AKAGERA Medicines, Inc. is a biotech company focused on the discovery and development of novel lipid nanoparticle formulations of antibacterial drugs and mRNA vaccines to treat tuberculosis, avian flu ...